Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$155,744,518
-$43,867,468 QoQ
Shares Held
4,288,120
0.0% QoQ
Ownership
4.04%
of shares outstanding
% of Portfolio
7.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EcoR1 Capital, LLC holds $1,935,887,028 across 29 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
|
22,970,388 | $600,445,942 | |
| 2 | ANAB |
Anaptysbio, Inc
|
7,880,094 | $531,906,345 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
4,824,469 | $155,492,635 | |
| 4 | CGON |
CG Oncology, Inc.
|
1,494,300 | $106,170,015 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
1,389,276 | $75,771,113 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
6,728,116 | $72,865,496 | |
| 7 | TRAX |
First Tracks Biotherapeutics, Inc.
|
3,174,519 | $63,871,322 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
|
1,667,119 | $49,980,227 |
All Filings in CRNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $155,744,518 | 4,288,120 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $199,611,986 | 4,288,120 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $178,600,198 | 4,288,120 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $123,326,331 | 4,288,120 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $143,823,544 | 4,288,120 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $219,251,575 | 4,288,120 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $219,122,932 | 4,288,120 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $186,119,246 | 4,155,375 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $194,513,103 | 4,155,375 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $71,605,354 | 2,012,517 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,510,021 | 1,530,263 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,971,339 | 1,330,263 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $21,364,023 | 1,330,263 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,343,812 | 1,330,263 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,126,365 | 1,330,263 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,809,404 | 1,330,263 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,345,087 | 790,209 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,766,701 | 590,169 | Shares | Sole | 2022-02-14 | |
| 2020-06-30 | $15,063,731 | 859,802 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,145,000 | 350,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||